Prosecution Insights
Last updated: October 25, 2026

Morse, Barnes-Brown & Pendleton, P.C.: all pending office actions

← Back to Morse, Barnes-Brown & Pendleton, P.C.

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19448634 ARMED CAR-MACROPHAGE COMPOSITIONS AND METHODS OF USE THEREOF Renabio Therapeutics, Inc. JOHNSON, ALLISON MARIE 1638 §102Other Non-Final OA — Pending Jan 14, 2026
19407141 LIGAND-DRUG CONJUGATES Tripartite Therapeutics Inc. PUTTLITZ, KARL J 1646 §102§112 Final Rejection — Pending Dec 03, 2025
19397515 UNIVERSAL EARLY CANCER DIAGNOSTICS DANA-FARBER CANCER INSTITUTE, INC. MYERS, CARLA J 1682 §101§102§103§112DP Final Rejection — Pending Nov 21, 2025
19051958 PERSONALIZED-FIT NASAL DILATOR Breathewave Technologies Inc. YABUT, DIANE D 3771 §102§103§112 Non-Final OA — Pending Feb 12, 2025
19048696 PROSTAGLANDIN ANALOGS AND METHODS FOR SUSTAINED GLAUCOMA MANAGEMENT Peregrine Ophthalmic Pte. Ltd. BAEK, BONG-SOOK 1612 §102§103DP Non-Final OA — Pending Feb 07, 2025
18968750 CONTOUR-FIT NASAL DILATOR Breathewave Technologies Inc. DUBOSE, LAUREN 3771 §101§102§103§112 Non-Final OA — Pending Dec 04, 2024
18861916 AN APPARATUS PROVIDING COOLING OF SEAWATER SURFACES COMPRISING A BUBBLE CURTAIIN Oceantherm AS FIORELLO, BENJAMIN F 3678 §102§103§112 Non-Final OA — Pending Oct 31, 2024
18916572 REPROGRAMMING OF SOMATIC CELLS Whitehead Institute For Biomedical Research NOBLE, MARCIA STEPHENS 1632 §103§112 Non-Final OA — Pending Oct 15, 2024
18907240 METHOD FOR EFFICIENT DRUG ADMINISTRATION ACROSS THE BLOOD-BRAIN BARRIER AND USES THEREOF Carthera MATTSON, SEAN D 3798 §103 Final Rejection — Pending Oct 04, 2024
18885174 MOBILE INFRARED AND NEGATIVE OXYGEN ION EXPOSURE CHAMBER Henan Qianpeng Biopharmaceutical Co. Ltd. MOON, MATTHEW RYAN 3785 §103 Non-Final OA — Pending Sep 13, 2024
18797184 THERAPEUTIC COMPOUNDS AND COMPOSITIONS Cadrenal Therapeutics, Inc. LEESER, ERICH A 1622 §102DP Non-Final OA — Pending Aug 07, 2024
18832837 A METHOD OF FORMING A COMPOSITION COMPRISING A PROBIOTIC MICRO-ENCAPSULATED IN A DENATURED PLANT PROTEIN MATRIX Anabio Technologies Ltd. WEBB, WALTER E 1612 §102§103 Non-Final OA — Pending Jul 24, 2024
18773428 METHODS OF EDITING DNA METHYLATION Whitehead Institute For Biomedical Research LEE, JAE W 1656 §103§112 Non-Final OA — Pending Jul 15, 2024
18734819 SEAM TAPES AND METHODS OF MAKING THE SAME Bemis Associates, Inc. FISCHER, JUSTIN R 1749 §103 Final Rejection — Pending Jun 05, 2024
18652069 ADHESIVE PATCH AND METHODS OF MAKING THE SAME Bemis Associates, Inc. IMANI, ELIZABETH MARY COLE 1789 §103 Final Rejection — Pending May 01, 2024
18701596 OPTIMIZED BIOSYNTHESIS PATHWAY FOR CANNABINOID BIOSYNTHESIS Cellibre, Inc. LOUNTOS, GEORGE THEMISTOCLIS 1652 §102§103§112 Non-Final OA 84d Pending Apr 15, 2024
18635153 METHODS FOR REPROGRAMMING SOMATIC CELLS Whitehead Institute For Biomedical Research NOBLE, MARCIA STEPHENS 1632 §112 Non-Final OA — Pending Apr 15, 2024
18696878 MIRNA COMBINATION FOR THE PREVENTION AND TREATMENT OF CANCER Institut National De La Santé Et De La Recherche Medicale BRETZ, COREY LANE 1635 §102§103§112 Non-Final OA — Pending Mar 28, 2024
18611871 METHOD FOR TREATING ZIKA VIRUS INFECTION WITH QUERCETIN-CONTAINING COMPOSITIONS Quercis Pharma AG CRAIGO, BAHAR ALAWI 1699 §103DP Non-Final OA — Pending Mar 21, 2024
18687807 PEPTIDES WITH ANTIMICROBIAL ACTIVITIES Aimmax Therapeutics, Inc. BEANE, RANDALL L §102§103 Non-Final OA — Pending Feb 28, 2024
18587684 PURIFICATION METHOD OF MYCOBACTERIUM-DERIVED NANOCARRIER PROTEIN Nankai University FRONDA, CHRISTIAN L 1656 §103§112DP Non-Final OA — Pending Feb 26, 2024
18578949 IMPROVED METHOD FOR PRODUCING A COMPONENT BY MEANS OF ADDITIVE MANUFACTURING Rwth Aachen WANG, NICHOLAS A 1734 §112 Non-Final OA — Pending Jan 12, 2024
18391648 METHOD FOR IMPROVING DIABETIC WOUND HEALING USING MIR-200B Hungkuang University SAPKOTA, SURAJ 4100 §103 Non-Final OA — Pending Dec 20, 2023
18561857 PRISTINAMYCIN IA AND FLOPRISTIN COMBINATIONS IN TREATING OR PREVENTING BACTERIAL INFECTIONS Aimmax Therapeutics, Inc. BOWLES, DAVID PAUL 1654 §103 Non-Final OA — Pending Nov 17, 2023
18560883 ENGINEERED CELLS, ENZYMES, AND METHODS FOR PRODUCING CANNABINOIDS Cellibre, Inc. GORDON, MELENIE LEE 1651 §102§103§112 Non-Final OA 84d Pending Nov 14, 2023
18386551 CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO Whitehead Institute For Biomedical Research GROOMS, TIFFANY NICOLE 1637 §102§103§112 Non-Final OA — Pending Nov 02, 2023
18499169 OPHTHALMIC DRUG DELIVERY CARRIER AND METHOD FOR PREPARING THE SAME Chang Gung University LIEB, JEANETTE M 1654 §102 Non-Final OA — Pending Oct 31, 2023
18495731 METHODS AND COMPOSITIONS FOR IN VIVO DIRECT GENOME EDITING IN PLANTS The Regents of the University of California KUMAR, VINOD 1663 §103 Final Rejection 96d overdue Pending Oct 26, 2023
18286755 USE OF ANTIBODY IN ANTI-TUMOR TREATMENT Ad Pharmaceuticals Co., Ltd. LI, RUIXIANG 1674 §101§103§112Other Non-Final OA — Pending Oct 12, 2023
18286405 CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME The Children's Hospital of Philadelphia MARTIN, PAUL C 1653 §102§103§112 Non-Final OA 61d Pending Oct 11, 2023
18285494 CHEMICAL REPROGRAMMING OF HUMAN SOMATIC CELLS INTO PLURIPOTENT CELLS Peking University MIANO, JOSEPH PAUL 1631 §103Other Final Rejection — Pending Oct 03, 2023
18374326 INHIBITORS OF POSITIVE STRAND RNA VIRUSES National Health Research Institutes VALLE, ERNESTO 1623 §103 Final Rejection 34d Pending Sep 28, 2023
18372855 LIFTING YOKE Danhydra A/S VU, STEPHEN A 3654 §112 Non-Final OA — Pending Sep 26, 2023
18231009 METHOD FOR IMMUNE CELL TRACKING Megapro Biomedical Co., Ltd. LEWOCZKO, EVAN MICHAEL 1612 §103Other Final Rejection 70d Pending Aug 07, 2023
18209360 POLYPHARMACEUTICAL DRUG COMPOSITIONS AND RELATED METHODS Aveta Biomics, Inc. PURDY, KYLE A 1611 §103 Final Rejection 63d Pending Jun 13, 2023
18038943 MODULATING TRANSCRIPTIONAL CONDENSATES Whitehead Institute For Biomedical Research BUCHANAN, BAILEY CHEYENNE 1682 §102§103§112 Non-Final OA — Pending May 25, 2023
18034876 USE OF BRAIN ORGANOIDS AND SINGLE CELL GENOMICS TO UNDERSTAND AND TREAT NEURODEVELOPMENTAL AND NEUROPSYCHIATRIC DISORDERS Massachusetts Institute Of Technology KAPUSHOC, STEPHEN THOMAS 1683 §103§112 Non-Final OA — Pending May 01, 2023
18034669 DUAL TARGETING CHIMERIC ANTIGEN RECEPTORS The University of North Carolina at Chapel Hill HUYNH, PHUONG N 1641 §102§103§112 Final Rejection 66d overdue Pending Apr 28, 2023
18023086 METHODS OF PREPARING IRON COMPLEXES LG Bionano, LLC SAEED, ALI S 1616 §103§112 Non-Final OA 23d overdue Pending Feb 24, 2023
18021156 EX VIVO BRAIN TUMOR MODEL Massachusetts Institute Of Technology REGLAS, GILLIAN CHELSEA 1632 §102§103§112 Non-Final OA — Pending Feb 13, 2023
17945709 METHOD OF BIOMARKER DETECTION IN COMPANION ANIMALS Uni Pharma Co., LTD. HUANG, MICKEY NMN 1758 §103 Final Rejection 20d Pending Sep 15, 2022
17904035 Progesterone Combinations Glia, LLC HUANG, GIGI GEORGIANA 1613 §103DP Final Rejection — Pending Aug 11, 2022
17728927 THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS The Children's Hospital of Philadelphia WILSON, MICHAEL C 1638 §103§112 Non-Final OA — Pending Apr 25, 2022
17770281 COMPOSITIONS AND METHODS FOR ENHANCING DIFFERENTIATION OF STEM CELL-DERIVED BETA CELLS President and Fellows of Harvard College BARRON, SEAN C 1653 §103 Final Rejection — Pending Apr 19, 2022
17763509 HYPERBRANCHED CATIONIC POLYMERS USEFUL AS NUCLEIC ACID DELIVERY VECTORS FOR TRANSFECTING CELLS UNIVERSITY COLLEGE DUBLIN BAKSHI, PANCHAM 1623 §103DP Non-Final OA — Pending Mar 24, 2022
17763441 NANOPARTICLE COMPOSITIONS FOR GENE THERAPY UNIVERSITY COLLEGE DUBLIN LIPPOLIS, ALEXANDRA ROSE 1637 §102§103§112 Non-Final OA — Pending Mar 24, 2022
17588038 IN VIVO GUIDE RNA LIBRARIES AND METHODS OF MAKING THE SAME Whitehead Institute For Biomedical Research DHAR, MATASHA 1632 §103 Non-Final OA — Pending Jan 28, 2022
17615579 REPRODUCIBLE BRAIN ORGANOIDS AND METHODS OF MAKING The Broad Institute, Inc. BEHARRY, ZANNA MARIA 1632 §103§112 Final Rejection — Pending Nov 30, 2021
17611560 METHODS OF CHARACTERIZING AND UTILIZING AGENT-CONDENSATE INTERACTIONS Whitehead Institute For Biomedical Research PERREIRA, MELISSA JEAN 1618 §103 Non-Final OA — Pending Nov 15, 2021
17608463 PEPTIDE DERIVATIVES AND CONJUGATES THEREOF FOR TREATING CANCER The University of Sydney REYNOLDS, FRED H 1658 §103 Non-Final OA 85d overdue Pending Nov 02, 2021
17270253 DEVICES AND METHODS FOR ABLATING BIOLOGICAL TISSUE In Medical Group Pty Ltd. GUERRERO ROSARIO, ANA VERUSKA 3794 §103 Final Rejection — Pending Feb 22, 2021
17182044 GENE EXPRESSION-BASED BIOMARKER FOR THE DETECTION AND MONITORING OF BRONCHIAL PREMALIGNANT LESIONS Trustees Of Boston University GROSS, CHRISTOPHER M 1684 §103§112 Non-Final OA 53d overdue Pending Feb 22, 2021
17052798 IN VIVO HOMOLOGY DIRECTED REPAIR IN HEART, SKELETAL MUSCLE, AND MUSCLE STEM CELLS President and Fellows of Harvard College HUDSON, AMY ROSE 1636 §103§112 Non-Final OA — Pending Nov 03, 2020
17040967 METHODS AND ASSAYS FOR MODULATING GENE TRANSCRIPTION BY MODULATING CONDENSATES Massachusetts Institute Of Technology PERREIRA, MELISSA JEAN 1618 §103 Final Rejection 16d Pending Sep 23, 2020

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month